HC Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
HC Pharma
Largest movements
- Tangible fixed assets +€499,391
up €499,391 (+15.4%), from €3.2m to €3.7m
of which Plant, machinery and equipment: +€609,606
- Trade debts +€903,131
up €903,131 (+267.2%), from €338,029 to €1.2m
- Profit (loss) carried forward -€235,534
down €235,534 (-14.6%), from -€1.6m to -€1.9m
- Other debts -€191,520
down €191,520 (-4.0%), from €4.8m to €4.6m
- Gross operating margin -€188,540
down €188,540 (-16.3%), from €1.2m to €968,350
- Depreciation +€97,245
up €97,245 (+31.0%), from €313,479 to €410,724
- Staff costs -€70,098
down €70,098 (-8.1%), from €861,291 to €791,193
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,452,470 | €4,921,268 | +€468,798 | +10.5% |
| Fixed assets | 21/28 | €3,242,045 | €3,741,435 | +€499,391 | +15.4% |
| Tangible fixed assets | 22/27 | €3,242,045 | €3,741,435 | +€499,391 | +15.4% |
| Land and buildings | 22 | €1,879,349 | €1,774,796 | -€104,553 | -5.6% |
| Plant, machinery and equipment | 23 | €1,345,619 | €1,955,226 | +€609,606 | +45.3% |
| Furniture and vehicles | 24 | €17,077 | €11,414 | -€5,663 | -33.2% |
| Current assets | 29/58 | €1,210,425 | €1,179,832 | -€30,593 | -2.5% |
| Stocks and contracts in progress | 3 | €649,193 | €609,871 | -€39,322 | -6.1% |
| Stocks | 30/36 | €649,193 | €609,871 | -€39,322 | -6.1% |
| Amounts receivable within one year | 40/41 | €556,751 | €565,742 | +€8,991 | +1.6% |
| Trade receivables | 40 | €556,751 | €565,742 | +€8,991 | +1.6% |
| Cash at bank and in hand | 54/58 | €4,481 | €4,220 | -€261 | -5.8% |
| Total equity and liabilities | 10/49 | €4,452,470 | €4,921,268 | +€468,798 | +10.5% |
| Equity | 10/15 | -€757,014 | -€992,548 | -€235,534 | -31.1% |
| Contributions | 10/11 | €568,600 | €568,600 | = | 0.0% |
| Reserves | 13 | €292,986 | €292,986 | = | 0.0% |
| Distributable reserves | 133 | €292,986 | €292,986 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€1,618,600 | -€1,854,134 | -€235,534 | -14.6% |
| Amounts payable | 17/49 | €5,209,484 | €5,913,816 | +€704,332 | +13.5% |
| Amounts payable within one year | 42/48 | €5,209,484 | €5,913,816 | +€704,332 | +13.5% |
| Trade debts | 44 | €338,029 | €1,241,160 | +€903,131 | +267.2% |
| Suppliers | 440/4 | €338,029 | €1,241,160 | +€903,131 | +267.2% |
| Taxes, remuneration and social security | 45 | €104,794 | €97,515 | -€7,280 | -6.9% |
| Taxes | 450/3 | €7,663 | €4,635 | -€3,027 | -39.5% |
| Remuneration and social security | 454/9 | €97,132 | €92,879 | -€4,252 | -4.4% |
| Other amounts payable | 47/48 | €4,766,661 | €4,575,141 | -€191,520 | -4.0% |
| Remuneration, social security and pensions | 62 | €861,291 | €791,193 | -€70,098 | -8.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €313,479 | €410,724 | +€97,245 | +31.0% |
| Other operating charges | 640/8 | €9,829 | €9,810 | -€19 | -0.2% |
| Gross operating margin | 9900 | €1,156,890 | €968,350 | -€188,540 | -16.3% |
| Operating profit (loss) | 9901 | -€27,709 | -€243,377 | -€215,669 | -778.3% |
| Financial income | 75/76B | €12,509 | €8,869 | -€3,640 | -29.1% |
| Recurring financial income | 75 | €12,509 | €8,869 | -€3,640 | -29.1% |
| Financial charges | 65/66B | €601 | €839 | +€237 | +39.4% |
| Recurring financial charges | 65 | €601 | €839 | +€237 | +39.4% |
| Profit (loss) for the period before taxes | 9903 | -€15,801 | -€235,347 | -€219,546 | -1389.5% |
| Income taxes | 67/77 | €204 | €187 | -€16 | -8.0% |
| Profit (loss) for the period | 9904 | -€16,004 | -€235,534 | -€219,530 | -1371.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€16,004 | -€235,534 | -€219,530 | -1371.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.